快报！百亿市场风口已现？4D毫米波雷达加速上车，替代激光雷达指日可待？

百亿市场风口已现？4D毫米波雷达加速上车，替代激光雷达指日可待？

北京，2024年6月15日 - 近日，华为、蔚来等车企纷纷宣布推出以毫米波雷达取代激光雷达的智能驾驶解决方案，引发业内对4D毫米波雷达的关注。有分析人士认为，随着汽车智能化水平的不断提升，4D毫米波雷达将迎来快速发展机遇，百亿市场指日可待。

4D毫米波雷达是指能够同时获取目标的方位、距离、速度、高度四个信息的新一代毫米波雷达。 与传统毫米波雷达相比，4D毫米波雷达能够提供更加精准的三维感知能力，为自动驾驶系统提供更加可靠的数据支持。

近年来，随着车企对自动驾驶功能的不断投入，毫米波雷达的市场需求快速增长。 预计到2028年，中国市场车载毫米波雷达前装用量将超过6千万颗，复合增长率在20%以上。

在毫米波雷达市场中，传统毫米波雷达厂商占据主导地位，博世、大陆、电装、奥托立夫等四家厂商占据了全球近80%的市场份额。 然而，随着4D毫米波雷达技术的突破，国内毫米波雷达厂商正在加速追赶。

加特兰微电子科技（下称“加特兰”）是国内毫米波雷达芯片领域的头部的企业。 目前，加特兰的产品已经进入到20余家车企，实现了超200款车型搭载。截至2024年一季度，加特兰毫米波雷达芯片累计出货超800万颗；今年全年，该公司出货量将达到600万颗，搭载加特兰芯片的毫米波雷达在国内的市场份额有望超过20%。

陈嘉澍认为，全球法规对于主动安全都提出更高要求，主动安全配置普及率的要求持续提升，毫米波雷达作为唯一一个全天候、全工况的传感器，是主动安全必不可少的传感器。 此外，高速NOA、环线NOA和城市NOA等L2+功能快速落地，越来越多车企希望用成像雷达替代激光雷达，这驱动了成像毫米波雷达的发展。

相比之下，激光雷达的价格仍然居高不下，成本是其推广应用的最大障碍。 据亿欧智库的数据显示，4D毫米波雷达的价格仅为激光雷达的1/10左右。

有分析人士认为，随着4D毫米波雷达技术的成熟和成本的下降，其将逐步替代部分激光雷达，成为自动驾驶系统的主流感知传感器之一。 4D毫米波雷达的快速发展，将推动百亿市场加速扩容。

不过，也有专家指出，4D毫米波雷达的探测距离和精度仍然不及激光雷达，在一些复杂场景下的感知能力还有待提升。 未来，4D毫米波雷达和激光雷达有望协同发展，共同满足自动驾驶系统的高精度感知需求。

A Wave of "Kete Valuation" Sweeps Through the Market: 50 Stocks Poised for Strong Growth

Shanghai, China - June 17, 2024 - A recent surge in investor sentiment towards growth stocks, particularly in the healthcare and technology sectors, has been dubbed the "Kete Valuation" phenomenon, named after the Chinese pharmaceutical company C-Bridge (6160.HK). This trend is reminiscent of the "CATL Valuation" rally that occurred in 2021, driven by the strong performance of Contemporary Amperex Technology Co., Ltd. (300015.SZ).

The "Kete Valuation" is characterized by a sharp increase in the share prices of companies with promising growth prospects, often defying broader market trends. This is evident in the recent performance of 50 stocks identified by analysts as having significant growth potential. These stocks, spanning various industries including healthcare, technology, and consumer goods, have exhibited remarkable resilience amidst recent market volatility.

Factors Driving the "Kete Valuation"

Several factors are contributing to the "Kete Valuation" trend. Firstly, investors are increasingly seeking out companies that can deliver sustainable growth, particularly in the face of global economic uncertainties. Secondly, the easing of monetary policy in major economies is providing a supportive backdrop for riskier assets like growth stocks. Additionally, advancements in technology and innovation are creating new opportunities for companies in various sectors, fueling investor optimism.

Key Beneficiaries of the "Kete Valuation"

Among the 50 stocks identified as potential beneficiaries of the "Kete Valuation," C-Bridge (6160.HK) stands out as a frontrunner. The company's innovative cancer therapies and strong pipeline of new drugs have attracted significant investor interest. Other notable stocks include:

• Ascletis Pharma (1672.HK): A clinical-stage biopharmaceutical company developing novel therapies for cancer and viral diseases.

• Aier Eye Hospital Group (300015.SZ): A leading provider of comprehensive eye care services in China.

• Xiaomi Corporation (1810.HK): A global technology company known for its smartphones, smart home devices, and internet services.

Investment Implications

The "Kete Valuation" presents an opportunity for investors to capitalize on the growth potential of select companies. However, careful due diligence is crucial, as not all growth stocks are created equal. Investors should thoroughly evaluate a company's financial health, competitive landscape, and long-term growth prospects before making investment decisions.

The "Kete Valuation" highlights the evolving dynamics of the Chinese stock market, where investors are increasingly discerning and seeking out companies with genuine growth potential. This trend is likely to continue as China's economy transitions towards a more innovation-driven and knowledge-based model.